P450 Polypeptide Transgenic Plants for Brassinosteroid Biosynthesis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for increasing plant production and size are time-consuming and labor-intensive, such as traditional plant breeding, and genetic manipulation of plant characteristics through exogenous nucleic acids is less time-consuming but not widely applicable across plant species, particularly for efficiently enhancing growth-promoting hormones like brassinosteroids.
Innovation Solution
Introduction of isolated polynucleotides encoding P450 polypeptides with 85% or greater sequence identity to specific amino acid sequences, which catalyze enzymatic activities in the brassinosteroid biosynthesis pathway, such as the oxidation of campestanol to 6-deoxocathasterone, into transgenic plants using recombinant vectors and promoters like p326 or 35S to alter metabolic profiles and enhance growth traits.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If traditional plant breeding programs are used to increase plant production and size, then plant characteristics can be improved, but the process becomes time-consuming and labor-intensive
Solution Approach 1:
The patent changes the fundamental parameter of plant modification from gradual breeding selection to direct genetic manipulation by introducing exogenous nucleic acids encoding P450 polypeptides. This enables precise control over brassinosteroid biosynthesis pathway parameters, achieving rapid plant size and production increases without traditional breeding time constraints
Solution Approach 2:
The patent introduces exogenous nucleic acids and P450 polypeptides as intermediaries to directly modify plant metabolism. These introduced genetic elements act as mediators that catalyze the conversion of campestanol to 6-deoxocathasterone, bypassing the need for traditional breeding processes and enabling rapid phenotypic changes
2Loss of time
If exogenous nucleic acids are introduced to genetically manipulate plant characteristics, then the process is less time-consuming, but applicability across different plant species is limited
Solution Approach 1:
The patent employs universally conserved cytochrome P450 enzymes that perform the same catalytic function across different plant species. The introduced nucleic acids encode P450 polypeptides with broad substrate specificity and functional conservation, enabling the same genetic construct to be effectively applied across monocots, dicots, and other plant divisions, thus achieving multi-species versatility
3Quantity of substance
If P450 polypeptides are introduced to enhance brassinosteroid biosynthesis, then growth-promoting hormone levels increase, but metabolic resource allocation may be affected
Solution Approach 1:
The patent establishes continuous brassinosteroid production by introducing constitutively expressed P450 polypeptides that continuously catalyze the conversion of campestanol to 6-deoxocathasterone. This continuous enzymatic action maintains steady hormone levels without requiring repeated metabolic investments, optimizing energy utilization while sustaining enhanced growth promotion
Solution Approach 2:
The patent performs preliminary metabolic preparation by introducing P450 polypeptides that pre-establish the biosynthetic pathway capability before environmental stresses or growth demands occur. This preliminary genetic equipment allows plants to rapidly produce brassinosteroids when needed without the metabolic overhead of de novo pathway development
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Transgenic plants exhibit increased height, seed yield, drought tolerance, and altered metabolic profiles, including higher levels of sucrose, glutamate, and linoleic acid, demonstrating improved growth potential and efficiency in brassinosteroid biosynthesis.
Implementation Method 1
DWF4 catalyzes the oxidation of campestanol at C-22 to form 6-deoxocathasterone
Data Source
AI summary
Isolated polynucleotides, polypeptides, and transgenic plants are described. The transgenic plants can exhibit one or more altered phenotypic characteristics relative to a control plant, including increased height, increased seed weight, increased photosynthetic rates, decreased levels of campestanol, or increased levels of 6-deoxocathasterone.